{
    "fund_name": "Leverage Shares 3x Amazon ETP",
    "type": "ETP",
    "ucits": false,
    "replication_method": "physical",
    "leverage": true,
    "inverse": false,
    "derivatives": false,
    "swaps": false,
    "complex_factors": [
        "Leverage (3x)",
        "Daily rebalancing with compounding effect",
        "High volatility risk",
        "Short-term trading focus"
    ],
    "classification": "complex",
    "supporting_data": "The product is classified as complex under MiFID II due to several key factors: 1) It provides 3x daily leverage on Amazon stock, which introduces significant risk and requires sophisticated understanding. 2) The daily rebalancing mechanism creates compounding effects that can lead to unexpected returns over longer periods. 3) The product is explicitly stated to be suitable only for sophisticated investors who can monitor positions frequently. 4) The risk indicator is at the highest level (7/7), and the product carries warnings about potential total loss of investment. 5) The recommended holding period is just 1 day, indicating it's designed for short-term trading rather than long-term investment. While the replication method is physical (owning the underlying stock with margin), the leveraged nature and daily compounding make this product complex. The fact sheet confirms the use of margin (borrowing) to achieve the 3x exposure, which is a form of leverage that increases risk. The PRIIPs KID contains explicit warnings about the complexity of leveraged products and the need for daily monitoring, further supporting the complex classification.",
    "confidence": 95,
    "counter_argument": "One might argue that since the product uses physical replication (owning the underlying stock with margin) rather than synthetic replication with swaps, it should be considered non-complex. However, the 3x leverage and daily compounding effects create a risk profile that is materially different from the underlying asset and requires specialized knowledge to understand, which outweighs the physical replication aspect in this case.",
    "risk_level": "Very High (7/7)",
    "additional_notes": "The product's prospectus and fact sheet confirm that it is designed for sophisticated traders who understand leverage and daily rebalancing. The high risk level, potential for total loss, and need for frequent monitoring all point to this being a complex product under MiFID II."
}